A - Mergers and acquisitions

CANONSBURG, Pa., Sept. 16, 2025 /PRNewswire/ -- Aquatech has acquired Koch Technology Solutions' (KTS) direct lithium extraction (DLE) business, integrating the Li-Pro™ Lithium Selective Sorption (LSS) technology and extensive Li-Pro IP portfolio into the PEARL™ process technology platform. The acquisition of KTS' Li-Pro LSS technology adds direct lithium extraction to Aquatech's extensive process flowsheet IP, lithium conversion and crystallization capabilities. With this addition, Aquatech's PEARL platform becomes the only commercially proven, end-to-end flowsheet solution f

Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE:A) today announced it has acquired Sigsense Technologies, a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operations. Financial terms of the acquisition were not disclosed. Sigsense technology is already available to Agilent customers through CrossLab Connect, a suite of digital applications—inventory management, service management, asset monitoring, smart alerts, and asset lifecycle analytics—that improve lab performance. Integrated into the Agilent CrossLab Connect asset monitoring solution, Sigsense's algorithm tracks i

Acquisition will make electron capture dissociation (ECD) technology available to more biopharma researchers and labs globally Agilent Technologies Inc. (NYSE:A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass spectrometers that enables biological researchers to develop biotherapeutic products more quickly to treat disease. This is done by more comprehensively and precisely breaking the chemical bonds of complex biomolecules, enabling more complete, accurate, and detailed structural information to be obtained from them. "The talented tea

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent Technologies Inc. (NYSE:A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to study cancer. The acquisition complements Agilent's market-leading SureSelect portfolio and further augments Agilent's strategy to expand into the high-growth clinical research and diagnostics markets. The chemistries and assays from Avida Biomed are compatible wit

Agilent Technologies Inc. (NYSE:A) today announced it has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules. The acquisition broadens and extends Agilent's product portfolio and customer offerings, particularly in the chemical and biopharmaceutical industries for the analysis of natural and synthetic p

Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis Agilent Technologies Inc. (NYSE:A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that creates innovative analysis solutions in lab testing. Agilent will integrate the software, known as ACIES, into its industry-leading gas chromatography and mass spectrometry (GS/MS) platforms to improve the productivity, efficiency and accuracy of high-throughput labs the company serves around the world. With the acquisition, Agilent obtained the software and other assets

Agilent Technologies, Inc. (NYSE:A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience complements and expands Agilent's capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further serve the needs of the fast-growing precision medicine market. The addition of Resolution Bioscience's liquid biopsy-based diagnostic technologies strengthens Agilent's offerings to biopharma and clinical diagnostics customers and boosts growth opportunities in the company's diagnostics and genomics

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Psychedelics are slowly becoming more acceptable as a legitimate treatment option for various anxiety and depression related mental illnesses. Depression is one of the most common chronic neurological disorders in modern society. It is estimated that over 250 million people suffer from some form of depression around the world. And, according to a report by Research and Markets, the U.S. reported a sharp increase (~20%) in the number of prescriptions for antidepressants and anti-anxiety drugs during the global lockdown enforced to curb the spread of the pandemic. Furthermore, the World Health Organization indicated that the major barriers to effectiv